Migden, M., Schmults, C., Khushalani, N., Guminski, A. , Chang, A.L., Lewis, K. , Ansstas, G. , Bowyer, S. , Hughes, B. , Schadendorf, D. , Modi, B. , Dunn, L. , Flatz, L. , Hauschild, A. , Yoo, S.-Y. , Booth, J. , Seebach, F. , Lowy, I. , Fury, M. and Rischin, D. 2023. Phase 2 study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 Groups 1, 2, and 3. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s176. DOI:https://doi.org/10.25251/skin.7.supp.176.